ALLERCLEAR dexchlorpheniramine maleate 2 mg tablets blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

dexchlorpheniramine maleate, Quantity: 2 mg

MAH:

AFT Pharmaceuticals Pty Ltd

pharmaceutical_form:

Tablet, uncoated

composition:

Excipient Ingredients: maize starch; magnesium stearate; pregelatinised maize starch; lactose

administration_route:

Oral

units_in_package:

20s and 40s

prescription_type:

(S3) Pharmacist Only Medicine

therapeutic_indication:

ALLERCLEAR is indicated for symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and,angioedema. ALLERCLEAR may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and medicine reactions, including serum sickness.

leaflet_short:

Visual Identification: White to off white, round, flat faced beveled edge tablets, score on one side and plain on other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

authorization_status:

Registered

authorization_date:

2020-11-12